Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The "exposure–crossover design" helps assess individual changes in risk after events like car crashes.

Control variability makes it hard to confirm low-dose endocrine effects.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Certain blood cell ratios are higher in kids with alopecia areata and might help predict the disease.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Alopecia areata is more common in Black and Hispanic people but less diagnosed in those with lower socioeconomic status.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Hair analysis can confirm drug use but can't accurately measure how much was taken.

Presurgical models can effectively and affordably screen cancer prevention agents.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

The new method improves SNP analysis in genetic studies by combining tests, enhancing accuracy and cost-effectiveness.

Disease-specific tools better assess alopecia areata's impact on quality of life.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Proscar and Propecia, two drugs with the same ingredient but different dosages, have different prices, showing price discrimination in the pharmaceutical industry.

Simple methods using DHT levels effectively assess compliance.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Facial proportion is important in hair restoration surgery.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.

Large databases in research can lead to misleading conclusions due to biases and chance findings; researchers should analyze data more rigorously.

Finger length ratios don't predict baldness in men.

Doctors need to understand statistics to properly evaluate clinical trials for patient care.

People with facial disfigurements are judged more negatively, highlighting the social benefits of corrective surgery.

Hair analysis can track haloperidol dosage history.

Disease-specific tools better assess quality of life in alopecia areata patients.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Dermatology datasets need more diversity in skin tones and ethnic representation.